Market Whales and Their Recent Bets on BNTX Options
Portfolio Pulse from Benzinga Insights
Wealthy investors have taken a bearish stance on BioNTech (NASDAQ:BNTX) through options trading, with 63% of trades being bearish. The options activity suggests a price target range of $95 to $200. Despite a recent 6.46% price increase to $111.78, analysts have mixed ratings, with a consensus target price of $105.67.
September 13, 2024 | 2:04 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Wealthy investors are showing a bearish sentiment on BioNTech through options trading, with 63% of trades being bearish. The stock recently increased by 6.46% to $111.78, but analysts have mixed ratings with a consensus target price of $105.67.
The significant bearish options activity suggests that investors expect a decline in BioNTech's stock price. Despite a recent price increase, the mixed analyst ratings and bearish sentiment from options traders indicate potential downward pressure.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100